Vorhofflimmern

Hennersdorf, M.; Perings, Ch.; Strauer, Bodo E.; Kelm, M.

doi:10.1007/s001080170015

Cited by 7 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The prevalence of ischemic stroke in patients with nonrheumatic atrial fibrillation and hypertension or coronary heart disease is reported to be up to 2.0-5.6% (3,5). The therapy consists of either antiarrhythmic therapy or causal therapy of the underlying disease and additional anticoagulation (6). Therapy with an angiotensin-converting enzyme (ACE)-inhibitor can lower the incidence of atrial fibrillation in patients with heart failure due to myocardial infarction (7).…”

Section: Introductionmentioning

confidence: 99%

Prevalence of Paroxysmal Atrial Fibrillation Depending on the Regression of Left Ventricular Hypertrophy in Arterial Hypertension

Hennersdorf¹,

Schueller²,

Steiner³

et al. 2007

Hypertens Res

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Prevalence of Paroxysmal Atrial Fibrillation Depending on the Regression of Left Ventricular Hypertrophy in Arterial Hypertension

Hennersdorf¹,

Schueller²,

Steiner³

et al. 2007

Hypertens Res

View full text Add to dashboard Cite

“…16 Liegt eine strukturelle Herzerkrankung vor, so werden primär β-Blocker, Sotalol oder evtl. auch Amiodaron eingesetzt[4,9]. [Randspalte 15 Keine strukturelle Herzkrankheit: β-Blocker, Klasse-Ic-Antiarrhythmika] [Randspalte 16 Bei struktureller Herzerkrankung: β-Blocker, Sotalol oder Amiodaron] Das 42 ➤Risiko für eine arterielle Embolie bzw.…”

unclassified

Therapie des Vorhofflimmerns

Tebbenjohanns

Korte

2003

Der Internist

View full text Add to dashboard Cite

Atrial fibrillation is the most common cardiac arrhythmia in adults. Paroxysmal atrial fibrillation terminates spontaneously, whereas the persistent form terminates only after medical or electrical cardioversion. Permanent atrial fibrillation cannot be cardioverted. Restoration of sinus rhythm can be achieved by antiarrhythmic drugs or electrical cardioversion, both performed under continuous electrocardiographic monitoring. If atrial fibrillation has lasted longer than 48 hours or the precise time of onset cannot be determined, there are two alternative approaches: systemic anticoagulation to achieve an international normalised ratio (INR) of 2.0 to 3.0 for at least three weeks, followed by cardioversion; or cardioversion guided by transesophageal echocadiography indicating the absence of thrombus. Several drugs have been shown to be effective for the maintenance of sinus rhythm. Anticoagulant therapy is mandatory for a minimum of three weeks after cardioversion. In case of drug refractory, highly symptomatic atrial fibrillation the indication for radiofrequency catheter ablation should be discussed, although the value of this new method is still under evaluation.

show abstract

“…Vorhofflimmern ist weltweit die häufigste behandlungsbedürftige Herzrhythmusstörung (10). Ergebnisse der Framingham-Studie (2) erbrachten eine Prävalenz bis zu 3% in der Bevölkerung bis zum 65.…”

unclassified